← Leaderboards
Laura Rozek
Georgetown University
$5,698,652
Attributed
$10,874,047
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,874,047 · 7
By mechanism
R01$8,471,292 · 3
U01$2,017,135 · 1
R03$155,500 · 1
F32$143,200 · 1
P30$86,920 · 1
Top collaborators
- Maureen Agnes Sartor13 shared
- Kristen S. Purrington7 shared
- Elena Martinez Stoffel7 shared
- Nisha J D'Silva5 shared
Most similar at Georgetown University
Same institution · by research overlap
- Jeanne Mandelblatt$29,742,067
- Arnold L Potosky$11,589,176
- Marc D Schwartz$16,557,279
- Kenneth Tercyak$9,721,134
- Beth N Peshkin$1,323,730
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMolecularTumorSamplingGenomicsUniversitiesPathway InteractionsIncidenceEpigenetic ProcessBiological MarkersMutationGenesBaseSurvival RateMichiganSiteCohortRecurrenceAutomobile DrivingDiagnosisSmokingGrantEventResources
Grant awards (31)
Oral Dysplasias to Carcinomas: Multi-omics Study of Progression$659,515
U01 · FY2025 · DE · contact PI
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$634,182
R01 · FY2025 · CA · contact PI
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$182,047
R01 · FY2025 · CA · contact PI
Cancer Prevention & Control$53,271
P30 · FY2025 · CA · contact PI
Cancer Prevention & Control$18,104
P30 · FY2025 · CA · contact PI
Oral Dysplasias to Carcinomas: Multi-omics Study of Progression$650,973
U01 · FY2024 · DE · contact PI
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$560,797
R01 · FY2024 · CA · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$517,177
R01 · FY2024 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$154,306
R01 · FY2024 · CA · contact PI
Cancer Prevention & Control$15,545
P30 · FY2024 · CA · contact PI
Oral Dysplasias to Carcinomas: Multi-omics Study of Progression$706,647
U01 · FY2023 · DE · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$575,080
R01 · FY2023 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$615,500
R01 · FY2022 · CA · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$584,593
R01 · FY2022 · CA
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$1
R01 · FY2022 · CA · contact PI
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort$655,222
R01 · FY2021 · CA · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$584,072
R01 · FY2021 · CA
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$216,973
R01 · FY2021 · CA
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$575,516
R01 · FY2020 · CA
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$421,253
R01 · FY2015 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$185,506
R01 · FY2015 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$410,990
R01 · FY2014 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$192,127
R01 · FY2014 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$436,873
R01 · FY2013 · CA · contact PI
Transcriptomic effects of curcumin and piperine in breast stem cells$77,750
R03 · FY2013 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$476,822
R01 · FY2012 · CA · contact PI
Transcriptomic effects of curcumin and piperine in breast stem cells$77,750
R03 · FY2012 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$492,255
R01 · FY2011 · CA · contact PI
Methylation patterns in colorectal cancer$50,428
F32 · FY2007 · CA · contact PI
Methylation patterns in colorectal cancer$48,796
F32 · FY2006 · CA · contact PI
Methylation patterns in colorectal cancer$43,976
F32 · FY2005 · CA